A Missing Link in Genotype-Directed Cancer Therapy

被引:81
作者
Bernards, Rene [1 ,2 ]
机构
[1] Netherlands Canc Inst, Div Mol Carcinogenesis, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands
[2] Netherlands Canc Inst, Canc Genom Ctr, NL-1066 CX Amsterdam, Netherlands
关键词
INHIBITION; VEMURAFENIB; EGFR;
D O I
10.1016/j.cell.2012.10.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Genotype-directed therapy holds great promise for the treatment of cancer, but crosstalk between signaling pathways often confounds simple genotype-drug response relationships. To deliver on the promise of precision medicine, a coordinated effort is needed to make a comprehensive inventory of the many signaling feedback circuits that exist in cancer cells.
引用
收藏
页码:465 / 468
页数:4
相关论文
共 9 条
[1]  
[Anonymous], 2011, PREC MED BUILD KNOWL
[2]   AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and Activity [J].
Chandarlapaty, Sarat ;
Sawai, Ayana ;
Scaltriti, Maurizio ;
Rodrik-Outmezguine, Vanessa ;
Grbovic-Huezo, Olivera ;
Serra, Violeta ;
Majumder, Pradip K. ;
Baselga, Jose ;
Rosen, Neal .
CANCER CELL, 2011, 19 (01) :58-71
[3]   Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation [J].
Chapman, Paul B. ;
Hauschild, Axel ;
Robert, Caroline ;
Haanen, John B. ;
Ascierto, Paolo ;
Larkin, James ;
Dummer, Reinhard ;
Garbe, Claus ;
Testori, Alessandro ;
Maio, Michele ;
Hogg, David ;
Lorigan, Paul ;
Lebbe, Celeste ;
Jouary, Thomas ;
Schadendorf, Dirk ;
Ribas, Antoni ;
O'Day, Steven J. ;
Sosman, Jeffrey A. ;
Kirkwood, John M. ;
Eggermont, Alexander M. M. ;
Dreno, Brigitte ;
Nolop, Keith ;
Li, Jiang ;
Nelson, Betty ;
Hou, Jeannie ;
Lee, Richard J. ;
Flaherty, Keith T. ;
McArthur, Grant A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26) :2507-2516
[4]   EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF-Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib [J].
Corcoran, Ryan B. ;
Ebi, Hiromichi ;
Turke, Alexa B. ;
Coffee, Erin M. ;
Nishino, Michiya ;
Cogdill, Alexandria P. ;
Brown, Ronald D. ;
Della Pelle, Patricia ;
Dias-Santagata, Dora ;
Hung, Kenneth E. ;
Flaherty, Keith T. ;
Piris, Adriano ;
Wargo, Jennifer A. ;
Settleman, Jeffrey ;
Mino-Kenudson, Mari ;
Engelman, Jeffrey A. .
CANCER DISCOVERY, 2012, 2 (03) :227-235
[5]   Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer [J].
Duncan, James S. ;
Whittle, Martin C. ;
Nakamura, Kazuhiro ;
Abell, Amy N. ;
Midland, Alicia A. ;
Zawistowski, Jon S. ;
Johnson, Nancy L. ;
Granger, Deborah A. ;
Jordan, Nicole Vincent ;
Darr, David B. ;
Usary, Jerry ;
Kuan, Pei-Fen ;
Smalley, David M. ;
Major, Ben ;
He, Xiaping ;
Hoadley, Katherine A. ;
Zhou, Bing ;
Sharpless, Norman E. ;
Perou, Charles M. ;
Kim, William Y. ;
Gomez, Shawn M. ;
Chen, Xin ;
Jin, Jian ;
Frye, Stephen V. ;
Earp, H. Shelton ;
Graves, Lee M. ;
Johnson, Gary L. .
CELL, 2012, 149 (02) :307-321
[6]   The concept of synthetic lethality in the context of anticancer therapy [J].
Kaelin, WG .
NATURE REVIEWS CANCER, 2005, 5 (09) :689-698
[7]   Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR [J].
Prahallad, Anirudh ;
Sun, Chong ;
Huang, Sidong ;
Di Nicolantonio, Federica ;
Salazar, Ramon ;
Zecchin, Davide ;
Beijersbergen, Roderick L. ;
Bardelli, Alberto ;
Bernards, Rene .
NATURE, 2012, 483 (7387) :100-U146
[8]   Clinical application of pharmacogenetics [J].
Spear, BB ;
Heath-Chiozzi, M ;
Huff, J .
TRENDS IN MOLECULAR MEDICINE, 2001, 7 (05) :201-204
[9]   Cancer: Addiction to oncogenes - The Achilles heal of cancer [J].
Weinstein, IB .
SCIENCE, 2002, 297 (5578) :63-64